GLP-1 is a gut-derived hormone that promotes insulin secretion in response to food intake. The activation of GLP-1 receptors (GLP-1R) leads to reduced glucagon levels and slower gastric emptying, making GLP-1-based medications effective for managing type 2 diabetes. Subsequent research revealed that GLP-1 administration also decreases food intake through central nervous system pathways, which paved the way for their use in obesity treatment.
Recent investigations have uncovered additional benefits of GLP-1 drugs, extending to cardiovascular and renal health. Drucker delves into the mechanisms behind these effects, such as the reduction of systemic inflammation, and explores their implications for future clinical uses and drug development. Evidence suggests that GLP-1 therapies may also have a role in managing metabolic liver disease, with ongoing clinical trials examining these possibilities. Despite observed reductions in liver inflammation and kidney disease complications, the precise mechanisms of action are not yet fully understood. Additionally, GLP-1R agonists are known to modulate systemic inflammation through various cellular pathways and receptors, including those in the brain.
The potential of GLP-1 medications is now being investigated for neurological and psychiatric conditions, such as Parkinson’s disease, cognitive impairment, depression, and substance use disorders. Preliminary findings are promising, yet Drucker emphasizes the need for further research to validate these effects. “The initial focus of GLP-1 innovation was on glucose regulation and weight management,” Drucker notes. “The next phases appear poised to enhance health outcomes for individuals with a variety of chronic disorders.” He adds that numerous clinical trials are underway, and upcoming results are expected to broaden the clinical applications of GLP-1 therapies.
Related topics:
Starting a New Diabetes Treatment? 10 Questions to Ask Your Doctor
Gestational Diabetes: Latest Research Updates
Combination of Semaglutide and Very-Low Calorie Diet Shows Superior Diabetes Management
